Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

被引：0
|
作者：
Foong, Yi Chao [1 ]
Merlo, Daniel [2 ]
Gresle, Melissa [2 ]
Zhu, Chao [2 ]
Buzzard, Katherine [2 ]
Zhong, Michael [1 ]
Yeh, Wei [1 ]
Jokubaitis, Vilija [1 ]
Butzkueven, Helmut [1 ]
van der Walt, Anneke [1 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期
关键词：
ocrelizumab; multiple sclerosis; elderly; comparative efficacy; MSBase;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [1] Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
    Foong, Yi Chao
    Merlo, Daniel
    Gresle, Melissa
    Buzzard, Katherine
    Zhong, Michael
    Yeh, Wei Zhen
    Jokubaitis, Vilija
    Monif, Mastura
    Skibina, Olga
    Ozakbas, Serkan
    Patti, Francesco
    Grammond, Pierre
    Amato, Maria Pia
    Kalincik, Tomas
    Horakova, Dana
    Kubala Havrdova, Eva
    Weinstock-Guttman, Bianca
    Lechner Scott, Jeanette
    Boz, Cavit
    Sa, Maria Jose
    Butzkueven, Helmut
    van der Walt, Anneke
    Zhu, Chao
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (08): : 767 - 774
  • [2] Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
    Foong, Yi Chao
    Zhu, Chao
    Merlo, Daniel
    Gresle, Melissa
    Buzzard, Katherine
    Zhong, Michael
    Yeh, Wei
    Jokubaitis, Vilija
    Skibina, Olga
    Ozakbas, Serkan
    Patti, Francesco
    Grammond, Pierre
    Amato, Maria Pia
    Kalincik, Tomas
    Horakova, Dana
    Havrdova, Eva
    Weinstock-Guttman, Bianca
    Lechner-Scott, Jeannette
    Boz, Cavit
    Sa, Maria Jose
    Butzkueven, Helmut
    van der Walt, Anneke
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 32 - 33
  • [3] The Use of Interferon Beta and Glatiramer Acetate in Multiple Sclerosis
    Goodin, Douglas S.
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 13 - 25
  • [4] Persistence and adherence to interferon and glatiramer acetate in patients with multiple sclerosis
    Bartolome-Garcia, Emma
    Usarralde-Perez, Angela
    Sanmartin-Fenollera, Patricia
    Perez-Encinas, Monserrat
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2019, 26 (01) : 23 - 28
  • [5] Randomized study combining interferon and glatiramer acetate in multiple sclerosis
    Lublin, Fred D.
    Cofield, Stacey S.
    Cutter, Gary R.
    Conwit, Robin
    Narayana, Ponnada A.
    Nelson, Flavia
    Salter, Amber R.
    Gustafson, Tarah
    Wolinsky, Jerry S.
    ANNALS OF NEUROLOGY, 2013, 73 (03) : 327 - 340
  • [6] Quality of life in people with multiple sclerosis receiving glatiramer acetate or interferon in Greek clinical practice
    Mitsikostas, Dimos
    Bakirtzis, Christos
    Nikolaidis, Ioannis
    Tsimourtou, Vana
    Kountra, Persa
    Matsi, Stavroula
    Papadimitriou, Alexandros
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (06) : 311 - 322
  • [7] Glatiramer acetate for multiple sclerosis
    La Mantia, Loredana
    Munari, Luca M.
    Lovati, Roberta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [8] Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients
    Ganji, Ali
    Monfared, Mohsen Ebrahimi
    Shapoori, Shima
    Nourbakhsh, Parisa
    Ghazavi, Ali
    Ghasami, Keyvan
    Mosayebi, Ghasem
    CYTOKINE, 2020, 126
  • [9] Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis
    Ytterberg, C.
    Johansson, S.
    Anderson, M.
    Olsson, D.
    Link, H.
    Holmqvist, L. W.
    von Koch, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (02): : 96 - 99
  • [10] Glatiramer Acetate or Interferon-β for Multiple Sclerosis?A Guide to Drug Choice
    Ron Milo
    Hillel Panitch
    CNS Drugs, 1999, 11 : 289 - 306
12345